Core Viewpoint - The Hang Seng High Dividend Yield Index (HSSCHKY) has experienced a decline of 1.01% as of August 1, 2025, with mixed performance among constituent stocks [1] Group 1: Market Performance - China Telecom (00728) led the gains with an increase of 1.65%, while China Petroleum & Chemical Corporation (00386) saw the largest decline at 5.65% [1] - The Bosera Hang Seng High Dividend ETF (513690) decreased by 1.12%, with the latest price at 1.06 yuan, but has risen by 3.28% over the past two weeks as of July 31, 2025 [1][2] - Southbound funds recorded a net purchase of 131.26 billion HKD in Hong Kong stocks on July 31, with a cumulative net inflow of 1,356.48 billion HKD for July, marking a historical high for the year [1] Group 2: Fund Performance - The Bosera Hang Seng High Dividend ETF has a current scale of 48.20 billion yuan, with a net inflow of 4.57 billion yuan over the last 23 trading days [2] - The ETF's financing buy-in amount reached 630.26 million yuan, with a financing balance of 1,044.09 million yuan [2] - The ETF has achieved a net value increase of 41.43% over the past three years, ranking 150 out of 1,829 index equity funds [2] Group 3: Risk and Return Metrics - The ETF's Sharpe ratio for the past year is 1.97, indicating a favorable risk-adjusted return [3] - As of July 31, 2025, the ETF has a year-to-date relative drawdown of 0.39%, with a recovery period of 37 days [3] - The management fee for the ETF is 0.50%, and the custody fee is 0.10% [3] Group 4: Index Composition - The HSSCHKY Index aims to reflect the performance of high dividend securities listed in Hong Kong that can be traded through the Stock Connect [4] - The top ten weighted stocks in the index account for 29.19% of the total index, including Yanzhou Coal Mining Company (01171) and Hang Lung Properties (00101) [4]

智通财经8月1日电，截至发稿，南向资金净买入超50亿港元。 ...

（文章来源：每日经济新闻） 每经AI快讯，8月1日，截至发稿时，南向资金净买入额超30亿港元。 ...

Group 1 - The Hong Kong stock market experienced another adjustment today, with the Hang Seng Index falling by 1.6% and the Hang Seng China Enterprises Index and the CSI Hong Kong Stock Connect China 100 Index both declining by 1.7% [1] - Southbound funds recorded a net inflow of 13.1 billion HKD, marking the first time since April 9 that there have been three consecutive days of net inflows exceeding 10 billion HKD [1] Group 2 - The Hang Seng ETF, which tracks the Hang Seng Index, has a rolling price-to-earnings ratio of 11.4 times, with a valuation percentile of 52.0% since 2002 [2] - The Hang Seng China Enterprises Index ETF has a rolling price-to-earnings ratio of 10.4 times, with a valuation percentile of 63.6% since 2002 [2] - The CSI Hong Kong Stock Connect China 100 Index ETF has a rolling price-to-earnings ratio of 10.9 times, with a valuation percentile of 90.0% since 2020 [2]

证券时报•数据宝统计显示，7月31日恒生指数下跌1.60%，南向资金合计买入成交918.01亿港元，卖出 成交786.75亿港元，合计成交额1704.76亿港元，全天成交净买入131.26亿港元，连续6日净买入。 具体看，港股通（沪）买入成交582.38亿港元，卖出成交506.34亿港元，合计成交额1088.72亿港元，成 交净买入76.04亿港元；港股通（深）买入成交335.63亿港元，卖出成交280.41亿港元，合计成交616.04 亿港元，成交净买入55.22亿港元。（数据宝） 南向资金今日成交概况 | | 买入成交额 （亿港元） | 卖出成交额 （亿港元） | 成交净买入 （亿港元） | | --- | --- | --- | --- | | 港股通（深） | 335.63 | 280.41 | 55.22 | | 港股通（沪） | 582.38 | 506.34 | 76.04 | | 合计 | 918.01 | 786.75 | 131.26 | 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （原标题：南向资金今日净买入131.26亿港元） 7月31日南向资金全天成交额1704.7 ...

Group 1 - Southbound funds had a significant net purchase of 13.126 billion yuan today [1] - In the Hong Kong Stock Connect (Shanghai), the top net purchases were in the Yingfu Fund and Hang Seng China Enterprises, with net purchases of 2.405 billion HKD and 1.782 billion HKD respectively [1] - SMIC had the highest net sell amount, totaling 0.101 billion HKD [1] Group 2 - In the Hong Kong Stock Connect (Shenzhen), Kuaishou-W and Nanfang Hang Seng Technology received net purchases of 1.032 billion HKD and 0.973 billion HKD respectively [1] - Laopu Gold had the highest net sell amount in this segment, amounting to 0.279 billion HKD [1]

每经AI快讯，7月31日，截至目前，南向资金净买入额达120亿港元。 ...

近期医药行业可谓是利好不断！先有阿斯利康溢价全盘收购中国biotech亘喜生物，后有罗氏以超10亿美元的价格获得宜联生物c-MET ADC全球权益。此 外，恒瑞HER3 ADC药物喜获FDA快速通道资格。 而财报方面，药明康德交出史上最漂亮的Q2答卷，上半年归母净利润85.6亿元，同比增长101.9%。更可观的是，药明康德在手订单数再创新高，可以预期 其业绩的增长之路目前还没到顶。 于是乎很多投资者也不想错过本轮医药行情，纷纷下场购买相关ETF产品。而医药行业作为市场重要的分支，相关ETF数不胜数，跟踪的指数更是大相径 庭：一边是创新药的火爆行情，另一边则是医疗、中药等细分领域的平淡表现。 以中证指数为例，截至7月30日，中证港股生物科技主题指数年内涨幅108.46%，领跑所有中证主题指数表现；与创新药相关的中证指数亦位居前列，中证 港股通创新药指数年内涨幅为107.32%，中证香港创新药指数年内涨幅为101.63%。 与此同时，中证医疗指数年内涨幅为14.48%，中证全指医疗器械指数年内涨幅为6.99%，中证中药指数年内涨幅仅为1.61%。 中证医药相关指数分化加剧 | 指数名称 | 指数类型 | ם אפ ...

人民财讯7月31日电，南向资金持续流入，截至目前，净买入额达130亿港元。 ...

每经AI快讯，7月31日，截至目前，南向资金净买入额达110亿港元。 （文章来源：每日经济新闻） ...